Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin1 predicts survival in patients with advanced gastric cancer.

Aktaş SH, Akbulut Yazici HO, Zengin N, Akgün HN, Üstüner Z, Içli F.

Turk J Med Sci. 2017 Apr 18;47(2):399-406. doi: 10.3906/sag-1509-80.

PMID:
28425270
2.

Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG).

İçli F, Altundağ K, Akbulut H, Paydaş S, Başaran G, Saip P, Doğu GG, Eralp Y, Uslu R, Sevinç A, Onur H, Mandel NM, Sezgin C, Altınbaş M, Güler N, Işıkdoğan A, Gökmen E, Uygun K, Üstüner Z, Yaren A, Demirkan B, Coşkun U, Ata A, Özkan M, Arican A.

Breast Cancer. 2015 Sep;22(5):480-5. doi: 10.1007/s12282-013-0506-y. Epub 2013 Dec 12.

PMID:
24338610
3.

Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography.

Ustuner Z, Akay OM, Keskin M, Kuş E, Bal C, Gulbas Z.

Med Oncol. 2012 Dec;29(5):3125-8. doi: 10.1007/s12032-012-0274-0. Epub 2012 Jun 14.

PMID:
22696065
4.

Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.

Ertan E, Soydinc H, Yazar A, Ustuner Z, Tas F, Yasasever V.

Tumori. 2011 May-Jun;97(3):286-9. doi: 10.1700/912.10023.

PMID:
21789004
5.

Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients.

Saip R, Sen F, Vural B, Ugurel E, Demirkan A, Derin D, Eralp Y, Camlica H, Ustuner Z, Ozbek U.

J BUON. 2011 Apr-Jun;16(2):241-6.

6.

Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography.

Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z.

Med Oncol. 2009;26(3):358-64. doi: 10.1007/s12032-008-9129-0. Epub 2008 Nov 20.

PMID:
19021004
7.

XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer.

Sakar B, Gumus M, Basaran M, Argon A, Ustuner Z, Ustaoglu MA, Saglam S, Guney N, Tenekeci AN, Aykan NF.

Oncology. 2007;73(5-6):298-304. doi: 10.1159/000132395. Epub 2008 May 14.

PMID:
18477855
8.

Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.

Ustuner Z, Saip P, Yasasever V, Vural B, Yazar A, Bal C, Ozturk B, Ozbek U, Topuz E.

Med Oncol. 2008;25(4):394-9. doi: 10.1007/s12032-008-9052-4. Epub 2008 Mar 4.

PMID:
18317954
9.

Clinical outcome of rhabdomyosarcoma in adolescent and adult patients: single center experience from Turkey.

Ustuner Z, Basaran M, Dizdar Y, Agaoglu FY, Bilgic B, Sakar B, Basaran GA, Darendeliler E, Ozger H, Onat H, Bavbek S.

Tohoku J Exp Med. 2007 Nov;213(3):221-9.

10.

Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute.

Yazar A, Ustüner Z, Sakar B, Kaytan Sağlam E, Camlica H, Aykan F.

Med Oncol. 2007;24(4):384-7.

PMID:
17917086
11.

Skull Base Plasmacytoma in a Patient with Light Chain Myeloma.

Ustuner Z, Basaran M, Kiris T, Bilgic B, Sencer S, Sakar B, Dizdar Y, Bavbek S, Onat H.

Skull Base. 2003 Aug;13(3):167-171.

12.

Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.

Vural B, Chen LC, Saip P, Chen YT, Ustuner Z, Gonen M, Simpson AJ, Old LJ, Ozbek U, Gure AO.

Cancer. 2005 Jun 15;103(12):2575-83.

13.

The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

Tas F, Ustuner Z, Can G, Eralp Y, Camlica H, Basaran M, Karagol H, Sakar B, Disci R, Topuz E.

Acta Oncol. 2005;44(2):161-7.

PMID:
15788296
14.

Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis.

Sakar B, Ustuner Z, Karagol H, Aksu G, Camlica H, Aykan NF.

Am J Clin Oncol. 2004 Oct;27(5):489-93.

PMID:
15596917
15.

Perioperative immunonutrition ameliorates the postoperative immune depression in patients with gastrointestinal system cancer (prospective clinical study in 42 patients).

Ateş E, Yilmaz S, Erkasap S, Ihtiyar E, Kaya Y, Pehlivan T, Ustuner Z, Yasar B, Kiper H.

Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):250-4.

PMID:
15587331
17.

Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanoma.

Tas F, Yasasever V, Duranyildiz D, Camlica H, Ustuner Z, Aydiner A, Topuz E.

Am J Clin Oncol. 2004 Jun;27(3):225-8.

PMID:
15170138
18.

Massive and isolated metastases to spleen of uveal malignant melanoma.

Tas F, Ustuner Z, Buyukbabani N, Tenekeci N, Topuz E.

Retina. 2004 Feb;24(1):170-2. No abstract available.

PMID:
15076966
19.

Timing of death from tumor recurrence after curative gastrectomy for gastric cancer.

Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D, Aykan FN.

Am J Clin Oncol. 2004 Apr;27(2):205-9.

PMID:
15057162
20.

Diagnostic value of interleukin-6 and C-reactive protein in acute appendicitis.

Erkasap S, Ates E, Ustuner Z, Sahin A, Yilmaz S, Yasar B, Kiper H.

Swiss Surg. 2000;6(4):169-72.

PMID:
10967943

Supplemental Content

Loading ...
Support Center